Skip to main content
  • More from ADA
    • Diabetes
    • Diabetes Care
    • Diabetes Spectrum
    • ADA Standards of Medical Care
    • ADA Standards of Medical Care, Abridged
    • ADA Scientific Sessions Abstracts
    • BMJ Open Diabetes Research & Care
  • Subscribe
  • Log in
  • My Cart
  • Follow ada on Twitter
  • RSS
  • Visit ada on Facebook
Clinical Diabetes

Advanced Search

Main menu

  • Home
  • Current
    • Current Issue
    • Online Ahead of Print
    • ADA Standards of Medical Care
    • ADA Standards of Medical Care, Abridged
  • Browse
    • Issue Archive
    • Saved Searches
    • COVID-19 Article Collection
    • Quality Improvement Sucess Stories
    • ADA Standards of Medical Care
    • ADA Standards of Medical Care, Abridged
    • Clinical Compendia
  • Info
    • About the Journal
    • About the Editors
    • ADA Journal Policies
    • Instructions for Authors
  • Advertising
  • Reprints/Reuse
  • Subscriptions
    • Individual Subscriptions
    • Institutional Subscriptions and Site Licenses
    • Access Institutional Usage Reports
    • Purchase Single Issues
  • Alerts
    • E­mail Alerts
    • RSS Feeds
  • Podcasts
    • Diabetes Core Update
    • Special Podcast Series: Therapeutic Inertia
    • Special Podcast Series: Influenza Podcasts
    • Special Podcast Series: SGLT2 Inhibitors
    • Special Podcast Series: COVID-19
  • Submit
    • Submit a Manuscript
    • Submit Cover Art
    • Instructions for Authors
    • ADA Journal Policies
  • More from ADA
    • Diabetes
    • Diabetes Care
    • Diabetes Spectrum
    • ADA Standards of Medical Care
    • ADA Standards of Medical Care, Abridged
    • ADA Scientific Sessions Abstracts
    • BMJ Open Diabetes Research & Care

User menu

  • Subscribe
  • Log in
  • My Cart

Search

  • Advanced search
Clinical Diabetes
  • Home
  • Current
    • Current Issue
    • Online Ahead of Print
    • ADA Standards of Medical Care
    • ADA Standards of Medical Care, Abridged
  • Browse
    • Issue Archive
    • Saved Searches
    • COVID-19 Article Collection
    • Quality Improvement Sucess Stories
    • ADA Standards of Medical Care
    • ADA Standards of Medical Care, Abridged
    • Clinical Compendia
  • Info
    • About the Journal
    • About the Editors
    • ADA Journal Policies
    • Instructions for Authors
  • Advertising
  • Reprints/Reuse
  • Subscriptions
    • Individual Subscriptions
    • Institutional Subscriptions and Site Licenses
    • Access Institutional Usage Reports
    • Purchase Single Issues
  • Alerts
    • E­mail Alerts
    • RSS Feeds
  • Podcasts
    • Diabetes Core Update
    • Special Podcast Series: Therapeutic Inertia
    • Special Podcast Series: Influenza Podcasts
    • Special Podcast Series: SGLT2 Inhibitors
    • Special Podcast Series: COVID-19
  • Submit
    • Submit a Manuscript
    • Submit Cover Art
    • Instructions for Authors
    • ADA Journal Policies
Translating Research to Practice

A Review of “BMI-Mortality Paradox and Fitness in African American and Caucasian Men with Type 2 Diabetes”

  1. Adam T. Chrusch, MD and
  2. Neil Skolnik, MD
Clinical Diabetes 2013 Apr; 31(2): 73-75. https://doi.org/10.2337/diaclin.31.2.73
PreviousNext
  • Article
  • Figures & Tables
  • Info & Metrics
  • PDF
Loading

STUDY

Kokkinos P, Myers J, Faselis C, Doumas M, Kheirbek R, Nylen E: BMI-mortality paradox and fitness in African American and Caucasian men with type 2 diabetes. Diabetes Care 35:1021–1027, 2012.

SUMMARY

Objective. To assess the association between BMI, fitness, and mortality in men with type 2 diabetes and to explore racial differences in this association.

Design and methods. This was a prospective, observational cohort study of veterans (n = 4,156) from 1986 to 2010. The cohort consisted of 2,000 Caucasian men, 2,013 African-American men, and 143 men of unknown or undetermined race.

Information was accessed via patients' electronic medical records. Vital statistics assessed included BMI, cardiac risk factors, medications, and peak exercise capacity in metabolic equivalents (METs), evaluated by a standardized treadmill protocol.

All-cause mortality was accessed across BMI, race, and fitness categories. BMI ranges were 18.5–24.9 kg/m2 (normal weight, n = 668), 25–29.9 kg/m2 (overweight, n = 1,610), 30–34.9 kg/m2 (obese, n = 1,160), and ≥ 35 kg/m2 (obese II and III, n = 718). The fitness levels were divided into four categories based on the peak MET level attained before volitional failure: ≤ 5 METs (least fit, n = 1,162), 5.1–7.0 METs (moderately fit, n = 1,163), 7.1–8.7 METs (fit, n = 995), and > 8.7 METs (highly fit, n = 836).

Results. A total of 1,074 deaths occurred over a median time period of 7.5 years. An association was seen individually among age, hypertension, smoking, BMI, exercise capacity, and mortality. Mortality was reduced by 12% for every 1-MET increase in exercise capacity across the entire cohort.

There was an even greater reduction in mortality (18% per 1-MET increase) in the two highest BMI groups (BMI 30–34.9 and > 35 kg/m2) with increasing fitness. The reduction in risk with increased fitness was such that the group with risk factors in addition to diabetes who had a high fitness level had a lower risk of mortality than the group with no additional risk factors and a low fitness level (Figure 1).

When looking at the mortality rates compared to the BMI classes, there was a significantly higher mortality rate in the lowest BMI category. No significant difference in mortality was seen among the three highest BMI categories. The researchers attempted to correct for reverse-causation by removing those patients who died within 2 years and had an exercise tolerance of ≤ 5 METs. However, the inverse association between mortality rate and BMI remained.

Conclusion. This study supports the association between increased activity and decreased mortality regardless of race or BMI in patients with diabetes. This study also supports the previously described and consistently surprising finding of a low BMI being associated with increased mortality.

COMMENTARY

The rate of obesity in the United States and worldwide is increasing and is associated with an increase in type 2 diabetes. Six of the top 10 leading causes of death are directly associated with obesity.1

BMI-Mortality Paradox

Several studies have documented what has been called the “BMI-mortality paradox,” an observation that low BMI is associated with increased mortality. This is considered a paradox because most of the risk factors, including hypertension, hypercholesterolemia, and diabetes, are associated with higher BMIs, so a low BMI would be expected to decrease, not increase, mortality.2–4

The researchers in this study have confirmed that this paradox exists in male patients with diabetes across ethnicities. The risk of mortality in this study was 39.7% higher for patients in the lowest BMI group (< 25 kg/m2). The mortality rate for African Americans was statistically higher in the lowest BMI group than for Caucasians in the same group (45.6 vs. 35.6%). The researchers tried to control for reverse-causation by eliminating patients in the lowest exercise tolerance group who died within 2 years. However, the mortality trend remained.

Figure 1.
  • Download figure
  • Open in new tab
  • Download powerpoint
Figure 1.

Adjusted mortality risk within each fitness category for diabetic individuals with and without additional risk factors.

*Different from lowest fit category (≤ 5 METs) with no additional risk factors

This paradox remains unexplained. However, the most plausible explanation might be that a low BMI is actually a confounding variable, that is, a variable that is associated with mortality but does not actually contribute to mortality itself. In a population-based, observational study such as this one, low BMI may be seen in people with serious chronic illnesses that have not yet been diagnosed, such as uncontrolled diabetes or undiagnosed cancer. These groups of people would have a diminished life expectancy. The association between low BMI and higher mortality might actually reflect the fact that people with a low BMI may also have illnesses that are associated with a higher-than-average mortality.5,6

Mortality Risk Versus Fitness

The most important take-home point in this article is the association between fitness and all-cause mortality. This study adds further support to an expanding literature showing the beneficial effects of fitness on cardiovascular disease and mortality in individuals both with and without diabetes.7–10 For the entire cohort of patients in the study, the adjusted mortality rate was 12% lower for each 1-MET increase in fitness, as demonstrated on exercise stress testing.

To put the categories of fitness into perspective, two examples are helpful. Achieving 4 METs of activity would require being able to attain a 15 minutes/mile pace. Achieving > 8.8 METs of activity would be jogging at a 12 minutes/mile pace.

In this study, being able to walk or jog slightly faster than a 15 minutes/mile pace decreased the mortality risk by 44% for those who had no cardiovascular risk factors and 50% for those with cardiovascular risk factors, compared to the lowest level of fitness. As the cohort got progressively more fit, the benefit increased, although the increase was not as large as the increase seen between the least fit and moderately fit groups. Those in the study with cardiac risk factors who could jog at a 12 minutes/mile pace (5 mph, 8.8 METs) had an 87% decrease in their mortality risk. Figure 1 shows this relationship.

The relationship between fitness and mortality is important. Often, clinicians are too quick to write prescriptions to address cardiovascular risk factors with the goal of decreasing the probability of patients developing cardiovascular illness. Because of time constraints, physical activity counseling is often underemphasized. However, there is accumulating evidence that lifestyle modification can be accomplished in the office setting.11,12

This study shows that a small improvement in fitness significantly decreases mortality risk. In the Taichung Diabetes Study,8 exercise was correlated with a greater risk reduction, compared to lack of exercise, than abstaining from smoking and alcohol. The current recommendation for exercise for most patients is 150 total minutes/week of cardiovascular exercise.13

Patients are often overly ambitious when it comes to exercise and stop lifestyle modifications because they do not attain their lofty goals. Given the significant improvement in mortality with only moderate levels of physical fitness, this study adds credence to the idea of setting small, attainable goals that, when achieved, can have a large long-term effect on health and mortality.

Footnotes

  • Adam T. Chrusch, MD, CAQ Sports Medicine, is an assistant program director, and Neil Skolnik, MD, is an associate program director of the Abington Family Medicine Residency Program at Abington Memorial Hospital in Abington, Pa. Dr. Skolnik is also a professor of family and community medicine at Temple University School of Medicine in Philadelphia, Pa.

  • American Diabetes Association(R) Inc., 2013

REFERENCES

  1. ↵
    1. Centers for Disease Control and Prevention
    : 10 leading causes of death by age group, United States, 2009. Available from http://www.cdc.gov/Injury/wisqars/pdf/10LCD-Age-Grp-US-2009-a.pdf. Accessed 12 September 2012
  2. ↵
    1. Arena R,
    2. Lavie CJ
    : The obesity paradox and outcome in heart failure: is excess body-weight truly protective? Future Cardiol 6:1–6, 2010
    OpenUrlCrossRefPubMed
    1. Oreopoulos A,
    2. Kalantar-Zadeh K,
    3. Sharma AM,
    4. Fonarow GC
    : The obesity paradox in the elderly: potential mechanisms and clinical implications. Clin Geriatr Med 25:643–659, 2009
    OpenUrlCrossRefPubMedWeb of Science
  3. ↵
    1. McAuley PA,
    2. Kokkinos PF,
    3. Oliveira RB,
    4. Emerson BT,
    5. Myers JN
    : Obesity paradox and cardiorespiratory fitness in 12,417 male veterans aged 40–70 years. Mayo Clin Proc 85:115–121, 2010
    OpenUrlCrossRefPubMedWeb of Science
  4. ↵
    1. Pearl J
    : Why there is no statistical test for confounding, why many think there is, and why they are almost right. Los Angeles, Calif., University of California–Los Angeles Computer Science Department, Technical Report R-256, January 1998. Available from http://ftp.cs.ucla.edu/pub/stat_ser/R256.pdf. Accessed 9 January 2013
  5. ↵
    1. Crawford S
    : Correlation and regression. Circulation 114:2083–2088, 2006
    OpenUrlFREE Full Text
  6. ↵
    1. Church TS,
    2. LaMonte MJ,
    3. Barlow CE,
    4. Blair SN
    : Cardiorespiratory fitness and body mass index as predictors of cardiovascular disease mortality among men with diabetes. Arch Intern Med 165:2114–2120, 2005
    OpenUrlCrossRefPubMedWeb of Science
  7. ↵
    1. Lin C,
    2. Li C,
    3. Liu C,
    4. Lin W,
    5. Fuh M,
    6. Yang S,
    7. Lee C,
    8. Li T
    : Impact of lifestyle-related factors on all-cause and cause-specific mortality in patients with type 2 diabetes. Diabetes Care 35:105–112, 2012
    OpenUrlAbstract/FREE Full Text
    1. Myers J,
    2. Prakash M,
    3. Froelicher V,
    4. Do D,
    5. Partington S,
    6. Atwood JE
    : Exercise capacity and mortality among men referred for exercise testing. N Engl J Med 346:793–801, 2002
    OpenUrlCrossRefPubMedWeb of Science
  8. ↵
    1. Berry JD,
    2. Willis B,
    3. Gupta S,
    4. Barlow CE,
    5. Lakoski SG,
    6. Khera A,
    7. Rohatqi A,
    8. De Lemos JA,
    9. Haskel W,
    10. Lloyd-Jones DM
    : Lifetime risks for cardiovascular disease mortality by cardiorespiratory fitness levels measured at ages 45, 55, and 65 years in men: the Cooper Center Longitudinal Study. J Am Coll Cardiol 57:1604–1610, 2011
    OpenUrlCrossRefPubMedWeb of Science
  9. ↵
    1. Saaristo T,
    2. Moilanen L,
    3. Korpi-Hyövälti E,
    4. Vanhala M,
    5. Saltevo J,
    6. Niskanen L,
    7. Jokelainen J,
    8. Peltonen M,
    9. Oksa H,
    10. Tuomilehto J,
    11. Uusitupa M,
    12. Keinänen-Kiukaanniemi S
    : Lifestyle intervention for prevention of type 2 diabetes in primary health care: one-year follow-up of the Finnish National Diabetes Prevention Program (FIN-D2D). Diabetes Care 33:2146–2151, 2010
    OpenUrlAbstract/FREE Full Text
  10. ↵
    1. Ackerman RT
    : Translating the Diabetes Prevention Program into the community: the DEPLOY pilot study. Am J Prev Med 35:357–363, 2008
    OpenUrlCrossRefPubMedWeb of Science
  11. ↵
    1. Garber CE,
    2. Blissmer B,
    3. Deschenes MR,
    4. Franklin BA,
    5. Lamonte MJ,
    6. Lee IM,
    7. Nieman DC,
    8. Swain DP
    : American College of Sports Medicine position stand: Quantity and quality of exercise for developing and maintaining cardiorespiratory, musculoskeletal, and neuromotor fitness in apparently healthy adults: guidance for prescribing exercise. Med Sci Sports Exerc 43:1334–1359, 2011
    OpenUrlCrossRefPubMedWeb of Science
PreviousNext
Back to top
Clinical Diabetes: 31 (2)

In this Issue

April 2013, 31(2)
  • Table of Contents
  • Index by Author
Sign up to receive current issue alerts
View Selected Citations (0)
Print
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word about Clinical Diabetes.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
A Review of “BMI-Mortality Paradox and Fitness in African American and Caucasian Men with Type 2 Diabetes”
(Your Name) has forwarded a page to you from Clinical Diabetes
(Your Name) thought you would like to see this page from the Clinical Diabetes web site.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Citation Tools
A Review of “BMI-Mortality Paradox and Fitness in African American and Caucasian Men with Type 2 Diabetes”
Adam T. Chrusch, Neil Skolnik
Clinical Diabetes Apr 2013, 31 (2) 73-75; DOI: 10.2337/diaclin.31.2.73

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Add to Selected Citations
Share

A Review of “BMI-Mortality Paradox and Fitness in African American and Caucasian Men with Type 2 Diabetes”
Adam T. Chrusch, Neil Skolnik
Clinical Diabetes Apr 2013, 31 (2) 73-75; DOI: 10.2337/diaclin.31.2.73
del.icio.us logo Digg logo Reddit logo Twitter logo CiteULike logo Facebook logo Google logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
    • STUDY
    • SUMMARY
    • COMMENTARY
    • Footnotes
    • REFERENCES
  • Figures & Tables
  • Info & Metrics
  • PDF

Related Articles

Cited By...

More in this TOC Section

  • Racial and Ethnic Disparities in Prevalence and Care of Patients With Type 2 Diabetes
  • Regular Insulin Administered With the V-Go Disposable Insulin Delivery Device in a Clinical Diabetes Setting: A Retrospective Analysis of Efficacy and Cost
  • Overcoming Weight Bias in the Management of Patients With Diabetes and Obesity
Show more Translating Research to Practice

Similar Articles

Navigate

  • Current Issue
  • Papers in Press
  • Abridged Standards of Care
  • Archives
  • Submit
  • Subscribe
  • Email Alerts
  • RSS Feeds

More Information

  • About the Journal
  • Instructions for Authors
  • Journal Policies
  • Reprints and Permissions
  • Advertising
  • Privacy Policy: ADA Journals
  • Copyright Notice/Public Access Policy
  • Contact Us

Other ADA Resources

  • Diabetes
  • Diabetes Care
  • Diabetes Spectrum
  • Scientific Sessions Abstracts
  • Standards of Medical Care in Diabetes
  • BMJ Open - Diabetes Research & Care
  • Professional Books
  • Diabetes Forecast

 

  • DiabetesJournals.org
  • Diabetes Core Update
  • ADA's DiabetesPro
  • ADA Member Directory
  • Diabetes.org

© 2021 by the American Diabetes Association. Clinical Diabetes Print ISSN: 0891-8929, Online ISSN: 1945-4953.